v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net earnings (loss) $ 18,205 $ (12,143)
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 57,996 50,669
Stock-based compensation 10,049 13,789
Share of (earnings) losses of affiliates, net (24,213) (26,951)
Realized and unrealized (gains) losses on financial instruments, net 1,083 (1,429)
Deferred income tax expense (benefit) 11,054 (10,902)
Cash receipts from returns on equity method investments 11,400 12,552
Net cash received (paid) for interest rate swaps 1,991 4,564
Other charges (credits), net 5,687 398
Net change in operating assets and liabilities:    
Current and other assets (62,326) (42,539)
Payables and other liabilities (32,101) (280)
Net cash provided by (used in) operating activities (1,175) (12,272)
Cash flows from investing activities:    
Capital expended for property and equipment (43,963) (73,922)
Acquisition of real estate assets (93,709)  
Other investing activities, net 6 (293)
Net cash provided by (used in) investing activities (137,666) (74,215)
Cash flows from financing activities:    
Borrowings of debt 153,509 106,343
Repayments of debt (15,314) (39,284)
Proceeds (expenses) from exercise of stock options and other stock issuances 7,968 408
Other financing activities, net (5,304) (2,677)
Net cash provided by (used in) financing activities 140,859 64,790
Net increase (decrease) in cash, cash equivalents and restricted cash 2,018 (21,697)
Cash, cash equivalents and restricted cash at beginning of period 112,599 137,717
Cash, cash equivalents and restricted cash at end of period 114,617 116,020
Noncash activity:    
Property and equipment expenditures incurred but not yet paid $ 6,192 $ 14,639